Supplementary Table S2 from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S2. sgRNA sequences and Primer sequences used for CRISPR/Cas9 genome editing.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362542276
